NCT05714553 2025-07-18NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursNuCana plcPhase 1/2 Terminated19 enrolled
NCT00227019 2017-03-06Phase 2 Trial of Bevacizumab in Combination With PemetrexedStanford UniversityPhase 2 Completed16 enrolled 9 charts